Nicotine on Farsalinos

The Global Regulatory Paradox of Cannabis Versus Nicotine

Sun, 06 Sep 2026 00:00:00 +0000

A new Harm Reduction Journal paper by Konstantinos Farsalinos argues that global drug policy has become internally inconsistent, and the application of double standards is becoming the new “norm”.

Key Takeaways
#

Cannabis, a psychoactive substance linked to real risks of psychosis and cognitive decline, is rolling out globally under the promise of personal freedom.
At the same time, non-combustible nicotine products—like vapes, pouches, and snus, which don’t intoxicate and carry far lower toxicological risks than smoking—are getting banned or criminalized in dozens of countries.
This contradiction has been labeled a “regulatory paradox.” In both cases, it’s the combustion, not the drug itself, that drives most of the harm, yet policy treats them as opposites.
From a toxicological standpoint, smoke is smoke; cannabis smoke shares carcinogens and toxic pathways with tobacco smoke and may even deliver more tar per puff. Yet the restrictions focus on nicotine’s non-combustible forms while leaving cannabis smoking largely unchecked.
Neurocognitively, nicotine acts as a non-intoxicating stimulant with proven cognitive benefits like sharpened attention and working memory, whereas THC carries a well-documented, dose-dependent link to acute psychosis and cognitive impairment.
A double standard protecting youth runs through both markets: flavor bans and “gateway theory” fears are weaponized against vapes and pouches, while flavored, youth-appealing THC edibles and vapes proliferate with little regulatory pushback.
Sociologically, the “Iron Law of Prohibition” is playing out again: Australia’s 2024 e-cigarette restrictions coincided with an estimated 95.7% of its vape market going illicit—the same black-market dynamic regulators previously accepted as a lesson from cannabis and alcohol prohibition.
Bioethically, cannabis legalization is defended through “cognitive liberty” and adult autonomy, while nicotine regulation has swung toward “hard paternalism,” treating addiction as negating free will and denying smokers access to lower-risk substitutes. The comparison of dependence also contradicts the policy trend.
While nicotine has a higher capture rate among first-time users, cannabis use disorder is more prevalent at a population level and includes a clinically validated withdrawal syndrome, undercutting the idea that cannabis is simply the “safe” substance and nicotine the dangerous one.
Economically and in criminal-justice terms, the paper argues nicotine bans reproduce the very costs cannabis liberalization was meant to avoid: lost tax revenue, destroyed legitimate businesses, and enforcement resources funneled into policing a black market instead of advancing public health.

The Core Claim, Up Front
#

The argument is straightforward: if you separate THC and nicotine from their traditional delivery systems—smoked cannabis and combustible cigarettes—the toxicology simply doesn’t support current policy. Combustion, not the drug itself, is the primary driver of harm in both scenarios. Yet policy has moved in opposite directions: cannabis is heading toward liberalization, while nicotine is facing prohibition of exactly the products—e-cigarettes, snus, and pouches—that remove combustion from the equation.

SRNT Recommendations to US Physicians on Nicotine E-Cigarettes

Wed, 02 Sep 2026 00:00:00 +0000

The international Society for Research on Nicotine and Tobacco (SRNT) recently published in JAMA its recommendations for U.S. clinicians on e-cigarettes and smoking cessation. Here, I examine the scientific, clinical, and ethical foundations behind these guidelines. They mark a landmark shift toward active harm reduction for adult smokers in the United States, weighing robust clinical trial evidence against complex public health values.

Why were new recommendations for e-cigarettes & smoking cessation needed?
#

Combustible tobacco remains the leading cause of preventable death in the U.S., claiming nearly 500,000 lives each year. Although over 68% of adult smokers wanted to quit in 2022 and more than half attempted to do so, fewer than 10% succeeded. This high failure rate highlights the need to broaden the clinical toolkit with alternative strategies.

How Australia has Lost Control of the Nicotine Market?

Sun, 30 Aug 2026 00:00:00 +0000

“When Best Practice Falls Short.” Australia has long been praised as a world leader in tobacco regulation, shaping global standards via plain packaging and strong public‑health initiatives. Yet this image hides a serious strategic misstep. By rigidly following WHO‑endorsed “best practice” measures—namely heavy excise taxes and a medical‑only framework for nicotine vapes—Australia has unintentionally sparked a sovereignty crisis. The government has effectively abandoned its duty to oversee the market, handing control over to criminal networks.

The Global State of Tobacco Harm Reduction 2026

Sat, 29 Aug 2026 00:00:00 +0000

A 91-page situation report from Knowledge•Action•Change was recently released, the Global State of Tobacco Harm Reduction (GSTHR) 2026, covering tobacco harm reduction (THR) developments from January 2025 into early 2026. This report represents a single synthesis of data on smoking prevalence, safer nicotine product use, regulation, pricing, science and policy across more than 200 countries, and is released approximately every 2 years.

The Core Findings
#

Five findings define this edition:

What is the Electronic Cigarette

Wed, 26 Aug 2026 00:00:00 +0000

The electronic cigarette represents one of the most significant technological innovations of the last 20 years in the field of tobacco control. For a smoker being unable to quit by currently-approved methods and seeking a less harmful alternative, understanding the concept of vaping is the first step toward transitioning to a smoke-free lifestyle. Here are 5 key points you should know.

1. The Historical Search for a Solution: From Hon Lik to the Global Market
#

The modern history of the electronic cigarette began in 2003, when Chinese pharmacist Hon Lik, who lost his father to lung cancer, sought a way to consume nicotine without the toxic substances of combustion. His invention was based on the vaporization of liquid through heating. The product was released to the global market around 2006-2007, marking the start of the electronic cigarette era that allowed millions of smokers to abandon traditional cigarettes.

Nicotine pouches

Sun, 23 Aug 2026 00:00:00 +0000

Nicotine pouches are small pouches—smaller than a tea bag—placed under the upper lip for about 30 to 60 minutes.

What are the Key Characteristics & Ingredients?
#

Tobacco-Free: This is their fundamental difference from traditional Swedish snus.
Composition: They contain plant fibers (cellulose), pharmaceutical-grade nicotine, flavorings, sweeteners, glycerin, and potentially pH regulators.
Nicotine Content: Ranges from 2 to 16 mg per pouch, though products with much higher levels have appeared on the market.

How did they Evolve Historically?
#

Ancestors: Oral tobacco use spans centuries. Chewing tobacco, highly popular in America, spread to Europe around 1600. In Scandinavia, a variation mixed tobacco with salt and water for under-the-lip use. This wet snus became highly popular in the United States during the 19th century. However, it was impractical—it caused significant saliva production that couldn’t be swallowed without nausea, forcing users to spit.
The 1970s: Scientist Curt Enzell placed tobacco inside tea-bag pouches, tested them on himself, and finding they worked, paved the way for Scandinavian Snus.
The 2008 Breakthrough: Karl Fagerström—creator of the Fagerström Test for Cigarette Dependence and pioneer of medical nicotine replacement therapy—developed the first tobacco-free nicotine pouch.

What are the Main Differences from Cigarettes?
#

Slower Nicotine Absorption: Unlike conventional cigarettes, where nicotine absorption is extremely rapid—reaching peak blood levels in about 5 to 6 minutes—nicotine pouches take five to ten times longer. Studies show maximum blood concentration is reached in 30 to 60 minutes.
The Satisfaction Drawback: This slower absorption is considered a disadvantage. The rapid, sharp spikes in blood nicotine levels satisfy smokers and provide smoking’s greatest pleasure. Electronic cigarettes, by contrast, achieve nicotine delivery speed and quantity comparable to traditional cigarettes.

How About Safety and Public Health?
#

High Safety Profile: Among all tobacco harm reduction alternatives, nicotine pouches carry the highest safety profile. However, because they can still cause addiction, they are not recommended for non-smokers.
The “Swedish Success Story”: Sweden is the ultimate public health example—the only country in Europe (and likely the world) that is practically smoke-free, with a smoking rate under 5%. It achieved this milestone exclusively through widespread adoption of snus and nicotine pouches.
Different Delivery, Immense Benefit: While Sweden’s overall nicotine-use rate resembles the rest of Europe, Swedes consume it orally instead of burning and inhaling it. Consequently, Sweden records by far the lowest rates of cardiovascular and cancer mortality in Europe.
Combination Use for Cessation: Many smokers find standard nicotine replacements insufficient to stop cravings. For these individuals, combining electronic or heated cigarettes with nicotine pouches can successfully suppress the urge to smoke.

Nicotine on Farsalinos

The Global Regulatory Paradox of Cannabis Versus Nicotine

Key Takeaways #

The Core Claim, Up Front #

SRNT Recommendations to US Physicians on Nicotine E-Cigarettes

Why were new recommendations for e-cigarettes & smoking cessation needed? #

How Australia has Lost Control of the Nicotine Market?

The Global State of Tobacco Harm Reduction 2026

The Core Findings #

What is the Electronic Cigarette

1. The Historical Search for a Solution: From Hon Lik to the Global Market #